Transcranial Magnetic Stimulation (TMS) is now available for adolescents as young as 15, and insurance providers like Aetna are expanding their coverage to meet this growing demand. As of now, Aetna has updated their policies to cover TMS for adolescents aged 15 and older with Major Depressive Disorder (MDD), but this shift is…
September is Suicide Prevention Month in the U.S., a time to raise awareness about a crisis that affects millions of individuals and families. Suicide is the 10th leading cause of death in the country, with mental health challenges like depression playing a significant role in many cases. As a community, we must come…
Transcranial Magnetic Stimulation (TMS) has rapidly become one of the most effective treatments for depression and other mental health conditions. As its popularity grows, many clinic owners are asking themselves: how profitable is TMS, and what’s the best device to maximize that profit? The Growing Demand for TMS TMS is in high demand…
Phone: 833.3BUY.TMS (+1.833.3289.867)
Email: Sales@sebersmedical.com
Address: 230 S Broad Street, 17th Floor Philadelphia, PA 19102
Regulations in the United States
*United States Federal Law regulates the sale of Medical Devices. The Blossom TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients, who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. (K220625) All other devices on this website are not approved and/or cleared for use in treatment and/or diagnosis in the United States. All investigational devices must be labeled in accordance with the labeling requirements of the IDE regulation (§ 812.5) and bear a label that states:
“CAUTION.
Investigational Device. Restricted by federal (or United States) law to research use.”
© 2024 SEBERS MEDICAL
